Sedation in the intensive care unit

Continuing Education in Anaesthesia, Critical Care and Pain

Volumn 8, Issue 2, 2008, Pages 50-55

  Rowe, Katherine ^a   Fletcher, Simon ^a  

^a NORFOLK AND NORWICH UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 41249086238     PISSN: 17431816     EISSN: 17431824     Source Type: Journal    
DOI: 10.1093/bjaceaccp/mkn005     Document Type: Article

References (15)

1. Consales G, Chelazzi C, Rinaldi S, De Gaudio A R. Bispectral index compared to Ramsay score for sedation monitoring in intensive care units. Minerva Anestesiol 2006; 72: 329-36
2. Hutton P, Cooper GM, James FM, Butterworth JF. Fundamental Principles and Practice of Anaesthesia. Martin Dunitz Ltd, 2002
3. Barrientos-Vega R, Sanchez-Soria MM, Morales-Garcia C et al. Prolonged sedation of critically ill patients with midazolam or propofol: Impact on weaning and costs. Crit Care Med 1997; 25 33-44
4. Anis AH, Wang X, Leon H, Hall R. Economic evaluation of propofol for sedation of patients admitted to intensive care units. Anaesthesiology 2002; 96: 196-201
5. Peck TE, Hill SA, Williams M. Pharmacology for Anaesthesia and Intensive Care, 2nd Edn. Greenwich Medical Media Ltd, 2003
6. Wolf A, Weir P, Segar P, Stone J, Shield J. Impaired fatty acid oxidation in propofol infusion syndrome. Lancet 2001; 9256: 606-7
7. Howdieshell TR, Sussman A, Dipiro J, McCarten M, Mansberger A. Reliability of in vivo mixed venous oximetry during experimental hypertriglyceridemia. Crit Care Med 1992; 20: 999-1004
8. Jacobi J, Fraser GL, Coursin DB, et al. Clinical practice guidelines for the sustained use of sedatives and analgesics in the critically ill adult: Sedation and Analgesia Task Force of the American College of Critical Care Medicine. Crit Care Med 2002; 30: 119-41
9. Battershill AJ, Keating GM. Remifentanil; a review of its analgesic and sedative use in the intensive care unit. Drugs 2006; 66: 365-85
10. Delvaux B, Ryckwaert Y, Van Boven M, et al. Remifentanil in the intensive care unit: Tolerance and acute withdrawal syndrome after prolonged sedation. Anaesthesiology 2005; 102: 1281-2
11. Hall JE, Uhrich TD, Ebert TJ. Sedative, analgesic and cognitive effects of clonidine infusions in humans. Br J Anaesth 2001; 86: 5-11
12. Tripathi SS, Hunter JM. Neuromuscular blocking drugs in the critically ill. BJA: CEACCP 2006; 6: 119-23
13. Kollef MH, Levy NT, Ahrens TS, Schaiff R, Prentice D, Sherman G. The use of continuous i.v. sedation is associated with prolongation of mechanical ventilation. Chest 1998; 114: 541-8
14. Kress JP, Pohlman AS, O'Conner MF, et al. Daily interruption of sedation infusions in critically ill patients undergoing mechanical ventilation. N Engl J Med 2000; 342: 1471-7
15. Erman M, Seiden D, Zammit G, et al. An efficacy, safety, and dose-response study of Ramelteon in patients with chronic primary insomnia. Sleep Med 2006; 7: 17-24, Epub 2005